Entry

D02297            Mixture   Drug

Name

Emtricitabine and tenofovir disoproxil;
Truvada (TN)

Product

TRUVADA (A-S Medication Solutions), TRUVADA (Bryant Ranch Prepack), TRUVADA (DIRECT RX), TRUVADA (Gilead Sciences), TRUVADA (NuCare Pharmaceuticals), TRUVADA (RedPharm Drug)

Generic

EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (A-S Medication Solutions), EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (Amneal Pharmaceuticals NY LLC), EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (Amneal Pharmaceuticals NY LLC), EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (Amneal Pharmaceuticals NY LLC), EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (Apotex Corp.), EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (Aurobindo Pharma Limited), EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (AvKARE), EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (Bryant Ranch Prepack), EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (Cadila Healthcare Limited), EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (Camber Pharmaceuticals), EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (Cipla USA), EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (Cipla USA), EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (DIRECT RX), EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (Direct Rx), EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (DirectRx), EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (Exelan Pharmaceuticals), EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (Golden State Medical Supply), EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (Laurus Labs Limited), EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (Lupin Pharmaceuticals), EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (Macleods Pharmaceuticals Limited), EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (Major Pharmaceuticals), EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (Mylan Pharmaceuticals), EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (NorthStar RxLLC), EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (RedPharm Drug), EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (Strides Pharma), EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (Strides Pharma Science Limited), EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (Teva Pharmaceuticals USA), EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (Zydus Pharmaceuticals (USA))

Component

Emtricitabine [DR:D01199], (Tenofovir disoproxil fumarate [DR:D01982] | Tenofovir disoproxil phosphate [DR:D10834])

Class

Antiviral
DG01890 Nucleoside reverse transcriptase inhibitor (NRTI)
DG03107 Anti-HIV agent

Remark

Therapeutic category:

6250

ATC code:

J05AR03

Product:

D02297<JP/US>

Efficacy

Antiviral

Disease

HIV-1 infection [DS:H01563]

Target

HIV-1 reverse transcriptase [KO:K24802]

Pathway

ko03230

Viral genome structure

ko03240

Viral replication

ko03250

Viral life cycle - HIV-1

Interaction

Brite

Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
J ANTIINFECTIVES FOR SYSTEMIC USE
  J05 ANTIVIRALS FOR SYSTEMIC USE
   J05A DIRECT ACTING ANTIVIRALS
    J05AR Antivirals for treatment of HIV infections, combinations
     J05AR03 Tenofovir disoproxil and emtricitabine
      D02297  Emtricitabine and tenofovir disoproxil <JP/US>
USP drug classification [BR:br08302]
Antivirals
  Anti-HIV Combinations
   Emtricitabine/ Tenofovir Disoproxil Fumarate
    D02297  Emtricitabine and tenofovir disoproxil
Therapeutic category of drugs in Japan [BR:br08301]
6  Agents against pathologic organisms and parasites
  62  Chemotherapeutics
   625  Antivirals
    6250  Antivirals
     D02297  Emtricitabine and tenofovir disoproxil
Drug groups [BR:br08330]
Antiviral
  DG01890  Nucleoside reverse transcriptase inhibitor (NRTI)
   D02297  Emtricitabine and tenofovir disoproxil
  DG03107  Anti-HIV agent
   D02297  Emtricitabine and tenofovir disoproxil
Drug classes [BR:br08332]
Antiviral
  DG03107  Anti-HIV agent
   D02297  Emtricitabine and tenofovir disoproxil
Antimicrobials [BR:br08307]
Antivirals
  Genome replication inhibitor
   HIV reverse transcriptase inhibitor
    D02297  Emtricitabine and tenofovir disoproxil <JP/US>
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
  D02297
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
  D02297

Other DBs

PubChem:

7849356